BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18782075)

  • 1. Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.
    Heilpern D; Szilagyi A
    Rev Recent Clin Trials; 2008 Sep; 3(3):167-84. PubMed ID: 18782075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
    Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
    Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
    Meijer BJ; Dieleman LA
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S139-44. PubMed ID: 21992953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C; Whelan K; Lindsay JO
    Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of probiotics in inflammatory bowel diseases.
    Mach T
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
    Naseer M; Poola S; Ali S; Samiullah S; Tahan V
    Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics and the management of inflammatory bowel disease.
    Fedorak RN; Madsen KL
    Inflamm Bowel Dis; 2004 May; 10(3):286-99. PubMed ID: 15290926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics for the treatment of postoperative complications following intestinal surgery.
    Gionchetti P; Amadini C; Rizzello F; Venturi A; Poggioli G; Campieri M
    Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):821-31. PubMed ID: 14507591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation of the bacterial flora in inflammatory bowel disease.
    Marteau P; Seksik P; Shanahan F
    Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):47-61. PubMed ID: 12617882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics--role in inflammatory bowel disease.
    Gionchetti P; Amadini C; Rizzello F; Venturi A; Palmonari V; Morselli C; Romagnoli R; Campieri M
    Dig Liver Dis; 2002 Sep; 34 Suppl 2():S58-62. PubMed ID: 12408442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics and probiotics in treatment of inflammatory bowel disease.
    Gionchetti P; Rizzello F; Lammers KM; Morselli C; Sollazzi L; Davies S; Tambasco R; Calabrese C; Campieri M
    World J Gastroenterol; 2006 Jun; 12(21):3306-13. PubMed ID: 16733845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives.
    Roy S; Dhaneshwar S
    World J Gastroenterol; 2023 Apr; 29(14):2078-2100. PubMed ID: 37122604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Probiotics in Crohn's Disease and in Pouchitis.
    Guslandi M
    J Clin Gastroenterol; 2015; 49 Suppl 1():S46-9. PubMed ID: 26447964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics for inflammatory bowel disease: a critical appraisal.
    Sans M
    Dig Dis; 2009; 27 Suppl 1():111-4. PubMed ID: 20203506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.
    Sartor RB
    Gastroenterology; 2004 May; 126(6):1620-33. PubMed ID: 15168372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
    Marteau P; Sokol H; Dray X; Seksik P
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S228-34. PubMed ID: 20117346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease.
    Ghouri YA; Richards DM; Rahimi EF; Krill JT; Jelinek KA; DuPont AW
    Clin Exp Gastroenterol; 2014; 7():473-87. PubMed ID: 25525379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing bacteria-induced disease with bacteria.
    Matarese LE; Kandil HM
    Nutr Clin Pract; 2012 Apr; 27(2):242-6. PubMed ID: 22378800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota and inflammatory bowel disease.
    Hammer HF
    Dig Dis; 2011; 29(6):550-3. PubMed ID: 22179210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.